Study of Safety and Effects of MDMA-assisted Therapy for Treatment of PTSD
Clinical trial NCT04968938 · WITHDRAWN
Trial details
- NCT number
- NCT04968938
- Sponsor
- Resilient Pharmaceuticals
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-01
- Primary completion
- 2023-08-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.